Welcome to LookChem.com Sign In|Join Free

CAS

  • or

66158-41-6

Post Buying Request

66158-41-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/1-(4-fluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid/SAGECHEM/Manufacturer in China

    Cas No: 66158-41-6

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

66158-41-6 Usage

Description

1-(4-fluorobenzyl)-1,2-dihydro-2-oxopyridine-3-carboxylic acid is a pyridine derivative, a heterocyclic compound featuring a pyridine ring with a carboxylic acid group and a fluorobenzyl substituent. It is widely utilized in pharmaceutical research as a key component for the synthesis of drug molecules targeting various diseases.

Uses

Used in Pharmaceutical Research:
1-(4-fluorobenzyl)-1,2-dihydro-2-oxopyridine-3-carboxylic acid is used as a building block for the synthesis of drug molecules due to its unique chemical structure and potential to be modified for specific therapeutic applications.
Used in the Development of New Drugs:
1-(4-fluorobenzyl)-1,2-dihydro-2-oxopyridine-3-carboxylic acid is employed as a starting material for the creation of new drugs aimed at treating a range of diseases, including bacterial and viral infections, inflammation, and cancer. Its versatility and the possibility of structural modifications make it a valuable asset in medicinal chemistry and drug discovery.
Used in Medicinal Chemistry:
1-(4-fluorobenzyl)-1,2-dihydro-2-oxopyridine-3-carboxylic acid is used as a research tool in medicinal chemistry to explore its potential interactions with biological targets and its efficacy in treating specific medical conditions.
Used in Drug Discovery:
In the field of drug discovery, this chemical compound is used for identifying new therapeutic agents and understanding their mechanisms of action, which can lead to the development of innovative treatments for various illnesses.

Check Digit Verification of cas no

The CAS Registry Mumber 66158-41-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,1,5 and 8 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 66158-41:
(7*6)+(6*6)+(5*1)+(4*5)+(3*8)+(2*4)+(1*1)=136
136 % 10 = 6
So 66158-41-6 is a valid CAS Registry Number.

66158-41-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(4-fluorophenyl)methyl]-2-oxopyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names F2143-0012

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66158-41-6 SDS

66158-41-6Relevant articles and documents

Nicotinamide derivative and preparation method and application thereof

-

Paragraph 0060; 0073; 0074; 0075, (2018/07/30)

The invention discloses a novel compound N-3-(4-R2 substituted)-(1-R-substituted benzimidazole)-(1'-R3 substituted)-2'-oxa-nicotinamide derivative, and a preparation method and an application thereof.The structural formula of the compound is as shown in a formula I, in which R1, R2 and R3 are described in the claims and description. The compound has very good anti-diabetes activity, and can be used as therapeutic agent for treating diabetes in the field of preparing anti-diabetes drugs. The formula is as shown in the description.

NEW CHEMICAL COMPOUNDS

-

Page/Page column 24; 25, (2012/04/23)

The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.

1H - IMIDAZO [4, 5 - C] QUINOLINES

-

Page/Page column 46, (2011/12/04)

The present invention encompasses compounds of general formula (1), wherein the groups R1 to R7, Qa, Qb, L, n and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations containing such compounds and their use as medicaments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 66158-41-6